{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:17:22Z","timestamp":1740115042001,"version":"3.37.3"},"reference-count":21,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017183","name":"Janssen Scientific Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017183","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.vaccine.2024.126159","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T14:29:34Z","timestamp":1723127374000},"page":"126159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pre- and post-Ad26.COV2\u00b7S booster dose antibody levels predict COVID-19 disease risk"],"prefix":"10.1016","volume":"42","author":[{"given":"Sanne","family":"Roels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Bruckner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerald","family":"Sadoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicky","family":"C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Hagedoorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Heerwegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Stieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Le Gars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.vaccine.2024.126159_bb0005","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa2034201","article-title":"Interim results of a phase 1-2a trial of Ad26.COV2.S Covid-19 vaccine","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126159_bb0010","first-page":"1770","article-title":"Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis","volume":"26","author":"Huang","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"24","key":"10.1016\/j.vaccine.2024.126159_bb0015","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMp2211314","article-title":"A Covid-19 milestone attained - a correlate of protection for vaccines","volume":"387","author":"Gilbert","year":"2022","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126159_bb0020","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126159_bb0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(23)00001-4","article-title":"Tracking immune correlates of protection for emerging SARS-CoV-2 variants","volume":"23","author":"Nilles","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126159_bb0030","article-title":"Cell-based manufacturing technology increases antigenic match of influenza vaccine and results in improved effectiveness","volume":"11","author":"Rockman","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"19","key":"10.1016\/j.vaccine.2024.126159_bb0035","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1016\/j.vaccine.2024.03.079","article-title":"Safety, reactogenicity and immunogenicity of Ad26.COV2.S as homologous or heterologous COVID-19 booster vaccination: results of a randomized, double-blind, phase 2 trial","volume":"42","author":"Le Gars","year":"2024","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126159_bb0040","doi-asserted-by":"crossref","first-page":"23921","DOI":"10.1038\/s41598-021-03154-6","article-title":"Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation","volume":"11","author":"Huang","year":"2021","journal-title":"Sci Rep"},{"author":"CDER","key":"10.1016\/j.vaccine.2024.126159_bb0045"},{"author":"CHMP","key":"10.1016\/j.vaccine.2024.126159_bb0050"},{"issue":"10282","key":"10.1016\/j.vaccine.2024.126159_bb0055","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(21)00527-4","article-title":"WHO international standard for anti-SARS-CoV-2 immunoglobulin","volume":"397","author":"Kristiansen","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.126159_bb0060","unstructured":"GISAID. Tracking of hCoV-19 Variants. 2021; Available from: https:\/\/gisaid.org\/hcov19-variants\/."},{"author":"Centers for Disease Control and Prevention. Coronavirus","key":"10.1016\/j.vaccine.2024.126159_bb0065"},{"key":"10.1016\/j.vaccine.2024.126159_bb0070","doi-asserted-by":"crossref","DOI":"10.1093\/biostatistics\/kxac24","article-title":"A controlled effects approach to assessing immune correlates of protection","author":"Gilbert","year":"2022","journal-title":"Biostatistics"},{"author":"Polley","key":"10.1016\/j.vaccine.2024.126159_bb0075"},{"year":"2024","series-title":"LeDell, E, Kennedy, C, Lendle, S, van der Laan, M","author":"Polley","key":"10.1016\/j.vaccine.2024.126159_bb0080"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126159_bb0085","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/aje\/kwac020","article-title":"Evaluating confounding control in estimations of influenza antiviral effectiveness in electronic health plan data","volume":"191","author":"Htoo","year":"2022","journal-title":"Am J Epidemiol"},{"year":"2024","series-title":"R: A Language and Environment for Statistical Computing","author":"Core Team, R","key":"10.1016\/j.vaccine.2024.126159_bb0090"},{"issue":"12","key":"10.1016\/j.vaccine.2024.126159_bb0095","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/s41564-022-01262-1","article-title":"Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial","volume":"7","author":"Fong","year":"2022","journal-title":"Nat Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126159_bb0100","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1038\/s41467-023-39816-4","article-title":"Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2","volume":"14","author":"Hertz","year":"2023","journal-title":"Nat Commun"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2024.126159_bb0105","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0092-8674(02)00706-7","article-title":"Somatic hypermutation of immunoglobulin genes: merging mechanisms for genetic diversity","volume":"109","author":"Papavasiliou","year":"2002","journal-title":"Cell"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24008223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24008223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T22:09:35Z","timestamp":1737583775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24008223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":21,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0264410X24008223"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126159","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre- and post-Ad26.COV2\u00b7S booster dose antibody levels predict COVID-19 disease risk","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126159"}}